CLASS II Device recall · Reported 12 Apr 2017 · FDA Enforcement Report

Curity Eye Pad recalled by Covidien

Covidien is recalling Curity Eye Pad, distributed nationwide in the US. The recall was initiated on 3 Mar 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number beginning with: 12, 13, 14, 15, 16 Expiration Date: From February 2017 through November 2021
Quantity recalled1659500

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1741-2017
FDA event ID
76606
Recalling firm
Covidien, North Haven, CT
Classification
Class II
Status
Terminated
Recall initiated
3 Mar 2017
FDA classified
6 Apr 2017
Reported
12 Apr 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

3 Mar 2017Recall initiated by company
6 Apr 2017Classified by FDA+34 days
12 Apr 2017Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product sterility is compromised due to breach of sterile barrier

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Covidien Curity Eye Pad Item Code: 91650 The sterile eye pad is a device that consists of a pad made of various materials, such as gauze and cotton, intended for use as a bandage over the eye for protection or absorption of secretions. It is supplied sterile to allow for use in the operating room, and for application to the eye following injury and or surgery in order to reduce the likelihood of introduction of infection

Where it was distributed

Worldwide Distribution. US (Nationwide), Internationally to Canada, Australia, Brunei, Japan, Mexico, Philippines, Singapore, Andorra, Belgium, Botswana, Czech Republic, Denmark, Egypt, France, Greece, Hungary, Ireland, Israel, Italy, Kenya, Libya, Luxembourg, Mauritius, Namibia, Netherlands, Norway, Poland, Portugal, Russia, Russian Federation, Spain, Saudi Arabia, Seychelles, Slovakia, South Africa, Switzerland, UAE, and United Kingdom.

Nationwide

Questions about this recall

Why was it recalled?

Product sterility is compromised due to breach of sterile barrier

Which lots are affected?

Lot Number beginning with: 12, 13, 14, 15, 16 Expiration Date: From February 2017 through November 2021

Where was it sold?

Worldwide Distribution. US (Nationwide), Internationally to Canada, Australia, Brunei, Japan, Mexico, Philippines, Singapore, Andorra, Belgium, Botswana, Czech Republic, Denmark, Egypt, France, Greece, Hungary, Ireland, Israel, Italy, Kenya, Libya, Luxembourg, Mauritius, Namibia, Netherlands, Norway, Poland, Portugal, Russia, Russian Federation, Spain, Saudi Arabia, Seychelles, Slovakia, South Africa, Switzerland, UAE, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

6 other products · FDA event 76606

This product is part of a recall event; the main page for the event is Curity Wet Dressing 8 x 4 x, Sterile recalled by Covidien.

More recalls from Covidien

All 493

Other Test Kits & Diagnostics recalls

All 2,656